Max Healthcare Institute stock
Price history
−7.52% over the period1 year: from ₹1,168.90 (November 20, 2025) to ₹1,081.00 (November 20, 2026), −7.52%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 20, 2026 | ₹1,081.00 |
| October 30, 2026 | ₹860.00 |
| September 30, 2026 | ₹929.80 |
| August 31, 2026 | ₹1,042.10 |
| July 31, 2026 | ₹1,098.50 |
| June 30, 2026 | ₹1,129.25 |
| May 29, 2026 | ₹965.10 |
| April 30, 2026 | ₹993.05 |
| March 30, 2026 | ₹962.30 |
| February 27, 2026 | ₹1,091.95 |
| January 30, 2026 | ₹956.80 |
| December 31, 2025 | ₹1,045.10 |
| November 28, 2025 | ₹1,162.80 |
| November 20, 2025 | ₹1,168.90 |
At a glance
The company
Operates a network of multi-specialty and super-specialty hospitals in India, providing medical services across numerous specialties and home healthcare services
Latest results
Quarter to September 30, 2026 · EPS ₹4.24 (estimate ₹4.32)
Next event
TickerLandia's take on Max Healthcare Institute
- Priced as usual relative to earnings: P/E on the latest fiscal year 73 vs a median of 65 over its last 5 fiscal years.
- Pricier than similar companies: trailing 12-month P/E 67 vs 26 (+155%) in a group of 11.
- Strong point: Profitability (73/100 in its group). Weak point: Dividend (24/100).
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−8.81% from the 52-week high
Analysts · 28 analysts
Average target₹1,104.89+2.21% vs. price
Buy 22 · Hold 3 · Sell 3 · Buy
TickerLandia Fingerprint: Max Healthcare Institute
Compared with similar companies: very high price.
Financials and price compared with 19 companies in the medical care facilities industry, worldwide. Momentum and risk compared with 1,074 Asia-Pacific stocks.
Pricevery high91
How much it costs relative to what it produces.
Metric Value Position in group Forward P/E 41.3 92 P/E (trailing 12 months) 67.0 97 EV/EBITDA 40.0 92 Price/book 8.14 79 Price/sales 10.1 92 Profitabilityhigh73
How much it earns on revenue and capital.
Metric Value Position in group ROA 7.0% 50 ROE 12.8% 42 Gross margin 63.1% 97 Net margin 15.1% 87 Operating margin 21.4% 87 Earnings stabilityaverage57
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 1.6% 55 Loss-making yearscounts in reverse: lower means more earnings stability 0 of 5 annual reports 58 Growthhigh68
How fast revenue and earnings are growing.
Metric Value Position in group Earnings growth (year over year) −15.50% 18 Average revenue growth (3 years) +22.43% 92 Revenue growth (year over year) +20.30% 92 Financial strengthhigh67
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Current ratio 0.84 29 Net debt/EBITDAcounts in reverse: lower means more financial strength 1.25 87 Interest coverage 8.37 71 Debt/equitycounts in reverse: lower means more financial strength 0.33 81 Dividendlow24
How much it returns to shareholders, and for how long.
Metric Value Position in group Consecutive dividend years 4 years 19 Dividend yield 0.2% 15 Payout ratio 14.2% 38 Market momentumaverage58
How the stock has moved compared with the market.
Metric Value Position in group 1-year return −7.52% 37 Distance from 200-day average +6.84% 79 Riskaverage40
How much the price swings.
Metric Value Position in group Volatility (60 days) 32.0% 38 Maximum drawdown (12 months) 31.0% 43
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Max Healthcare Institute is priced as in the past and pricier than similar companies
On the latest fiscal year's earnings (2026), Max Healthcare Institute's P/E today is 73.2, in line with the median of its last 5 fiscal years (65.2; between 38.8 and 99.6 from 2022 to 2026). Max Healthcare Institute's P/E (trailing 12 months): 67.0, +155% against the median of a group of 11 similar companies (26.2).
Compared with 11 similar companies
| Metric | Max Healthcare Institute | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 67.0 | High | |
| Forward P/E | 41.3 | High | |
| Operating margin | 21.4% | High | |
| ROE | 12.8% | Middle | |
| Debt/equity | 0.33 | Low |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Max Healthcare Institute. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
₹25.69B
Latest quarter · Q3 2026
Net income
₹4.15B
Latest quarter · Q3 2026
Quarterly net margin
16.2%
Latest quarter · Q3 2026
Numbers and valuation
Full valuation- Market cap
- ₹921.84B
- P/E
- 67.0
- EPS
- ₹14.13
- Volume
- 1.48M
- Daily trading
- €39.19M
- Dividend yield
- 0.19%
- Last ex-dividend on July 3, 2026
How Max Healthcare Institute is changing
All resultsRevenue grew 27.3% a year on average over the last 5 years
Less cash than profit: free cash flow equal to 27% of net income
Shares outstanding up 13.2% in 5 years
Returns
Max Healthcare Institute returns with dividends
₹1,000 invested in Max Healthcare Institute 5 years ago, on November 22, 2021, would be worth ₹3,156 today: +215.57% in total, +25.88% per year. This is the price return only: dividends are excluded.
| Period | Max Healthcare Institute | ₹1,000 becomes |
|---|---|---|
| 1 month | +31.85% | ₹1,318 |
| 6 months | +0.49% | ₹1,005 |
| Year to date | +3.44% | ₹1,034 |
| 1 year | −7.36% | ₹926 |
| 3 years | +74.73% | ₹1,747 |
| 5 years | +215.57% | ₹3,156 |
From 1 year up with dividends reinvested, before taxes; under a year price only. Calculate your investment
The chart in detail
Max Healthcare Institute: technical analysis
Max Healthcare Institute shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 16.9% below its all-time closing high (₹1,301.40, July 3, 2025).
- Trend
- No clear trend
- RSI (14 sessions)
- 80
- Above 70: a strong rise in a short time
- vs 200-session average
- +6.84%
Active signals
Close above the high of the previous 55 sessions.
RSI above 70: the stock has risen a lot in a short time.
since November 16, 2026
Trading on November 20, 2026 was 2.4 times the 20-session average.
Support and resistance
Price areas where Max Healthcare Institute has stopped several times in the last year. They describe the chart; they are not forecasts.
- Resistance₹1,111.78+2.85%2 touches, last on May 21, 2026
- Last price₹1,081.00
- Support₹1,070.63−0.96%4 touches, last on September 21, 2026
- Support₹1,030.69−4.65%7 touches, last on September 17, 2026
- Support₹984.54−8.92%5 touches, last on September 7, 2026
Volatility and risk
- Volatility (60 sessions, annualised)
- 32.0%
- Largest fall in the last year
- −31.00%
Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Max Healthcare Institute: seasonality
Average monthly price change over 7 years
Over the last 7 years, the strongest month for Max Healthcare Institute has been June: +12.59% on average, positive in 5 years out of 6. The weakest has been October: −0.54% on average, positive in 4 years out of 7. November, the current month, has been positive in 4 years out of 6 (+6.84% on average).
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | −0.24% | −2.72% | 3 of 6 |
| February | +3.01% | +1.75% | 4 of 6 |
| March | +2.25% | +3.43% | 4 of 6 |
| April | +6.57% | +3.75% | 6 of 6 |
| May | −0.26% | −2.41% | 2 of 6 |
| June | +12.59% | +13.92% | 5 of 6 |
| July | +1.57% | −1.36% | 2 of 6 |
| August | +2.53% | −3.02% | 2 of 6 |
| September | +0.44% | −3.43% | 3 of 7 |
| October | −0.54% | +1.12% | 4 of 7 |
| November | +6.84% | +6.06% | 4 of 6 |
| December | +6.24% | +9.12% | 4 of 6 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Max Healthcare Institute and its competitors
Employing 15,114 people, Max Healthcare Institute Limited runs hospitals, clinics and diagnostic services across India through a tiered network of primary care clinics, multi-specialty hospitals and super-specialty facilities. Its clinical offer spans cardiac care, orthopaedics, oncology, neurosciences, nephrology, gastroenterology, obstetrics, eye care and robotic surgery, with organ transplants and bone marrow transplants among its specialised procedures.
- Headquarters
- Gurugram, India
- Employees
- 15,114
- Founded
- 2001
- Chief executive
- Abhay Soi
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| Max Healthcare InstituteMAXHEALTH | $9.95B | 21.4% | 67.0 | +0.49% |
| Ramsay Health CareRHC | $8.37B | 5.9% | 40.0 | +40.77% |
| Aier Eye Hospital Group300015 | $12.44B | 21.8% | 34.4 | −5.49% |
| Apollo Hospitals EnterpriseAPOLLOHOSP | $14.27B | 12.1% | 58.8 | +13.88% |
| Fortis HealthcareFORTIS | $6.47B | 17.1% | 56.8 | −15.35% |
| DavitaDVA | $10.13B | 15.2% | 12.2 | −18.20% |
Same industry or related industries, similar size. Compare Max Healthcare Institute with its competitors · Full profile
